Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

PRP is an effective and safe treatment for alopecia areata.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Valproic acid does not change biotinidase enzyme activity in children's blood.

Mutations in the ABCB6 gene cause Dyschromatosis Universalis Hereditaria.

PCOS is linked to low-grade chronic inflammation.

A 5-year-old girl with a rare genetic disorder, lipoid proteinosis, showed reduced new lesions but persistent scars after avoiding skin trauma.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Lipase H is important for hair follicle function and shaping hair fibers.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Dysregulated lipid metabolism may play a role in male pattern baldness.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

Biotin supplements may help hair regrowth in alopecia areata patients with low biotinidase activity.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

New and known mutations in the hairless gene cause a hair loss condition called Atrichia with papular lesions.

The project developed and tested a method using plasma rich platelets to treat hair loss.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

A simple method was developed to prepare concentrated platelet-rich plasma for use in healing and tissue repair.

A mutation in the SREBF1 gene causes both hereditary mucoepithelial dysplasia and IFAP syndrome, which are related conditions.